This review summarizes the evolution, current applications, and future directions of transcatheter valve technologies for adult valvular heart disease.
Answers are grounded in this paper and cite their sources.
Informs current transcatheter valve decisions; leaves open prospective validation of emerging applications in valvular disease.
The transcatheter valve technology pipeline has started as simple balloon valvuloplasty for the treatment of stenotic heart valves and evolved since the year 2000 to either repair or replace heart valves percutaneously with multiple devices. In this review, the present technology and its application are illuminated and a glimpse into the near future is dared from a physician's perspective.
No takes yet. Share an insight, caveat, or question.
Figulla et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: